Literature DB >> 23242112

Role of interleukin-32 in chronic rhinosinusitis.

Anjeni Keswani1, Robert C Kern, Robert P Schleimer, Atsushi Kato.   

Abstract

PURPOSE OF REVIEW: IL-32 is a recently described proinflammatory cytokine and has been reported to be involved in inflammatory diseases. The purpose of this review is to discuss the role of IL-32 in chronic rhinosinusitis (CRS). RECENT
FINDINGS: Two groups have recently reported data regarding the expression of IL-32 in CRS. IL-32 was induced by IFN-γ, TNF-α, dsRNA, and incubation with Th1 cells in primary nasal epithelial cells. IL-32 may be elevated in epithelial cells from patients with CRS without nasal polyps. IL-32 was significantly elevated in whole sinonasal tissue samples of nasal polyps compared with control tissue. IL-32 mRNA expression positively correlated with mRNA for CD3 and macrophage mannose receptor in nasal polyp tissue. Immunohistochemical studies demonstrated localization of IL-32 in epithelium, CD3(+) and CD68(+) cells, suggesting that epithelial cells, T cells, and macrophages are the major IL-32-producing cells in CRS. Activation of these cell types may trigger IL-32-related inflammation in CRS.
SUMMARY: Elevated levels of IL-32 may play a role in the pathogenesis of CRS through its role as a proinflammatory cytokine and as an endogenous enhancer of pathogen-dependent cytokine production.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23242112      PMCID: PMC3733344          DOI: 10.1097/ACI.0b013e32835b35d5

Source DB:  PubMed          Journal:  Curr Opin Allergy Clin Immunol        ISSN: 1473-6322


  49 in total

1.  Suppressing IL-32 in monocytes impairs the induction of the proinflammatory cytokines TNFalpha and IL-1beta.

Authors:  Jaewoo Hong; Suyoung Bae; Youngsun Kang; Doyoung Yoon; Xiyuan Bai; Edward D Chan; Tania Azam; Charles A Dinarello; Siyoung Lee; Erk Her; Gyujin Rho; Soohyun Kim
Journal:  Cytokine       Date:  2009-10-31       Impact factor: 3.861

2.  Interleukin-32: a cytokine and inducer of TNFalpha.

Authors:  Soo-Hyun Kim; Sun-Young Han; Tania Azam; Do-Young Yoon; Charles A Dinarello
Journal:  Immunity       Date:  2005-01       Impact factor: 31.745

3.  Interleukin-32 enhances cytotoxic effect of natural killer cells to cancer cells via activation of death receptor 3.

Authors:  Mi H Park; Min J Song; Min-Chul Cho; Dong C Moon; Do Y Yoon; Sang B Han; Jin T Hong
Journal:  Immunology       Date:  2012-01       Impact factor: 7.397

Review 4.  IL-32, a novel cytokine with a possible role in disease.

Authors:  C A Dinarello; S-H Kim
Journal:  Ann Rheum Dis       Date:  2006-11       Impact factor: 19.103

5.  Expression of interleukin-32 in the inflamed arteries of patients with giant cell arteritis.

Authors:  Francesco Ciccia; Riccardo Alessandro; Aroldo Rizzo; Simona Principe; Francesca Raiata; Alberto Cavazza; Giuliana Guggino; Antonina Accardo-Palumbo; Luigi Boiardi; Angelo Ferrante; Alfonso Principato; Annarita Giardina; Giacomo De Leo; Carlo Salvarani; Giovanni Triolo
Journal:  Arthritis Rheum       Date:  2011-07

6.  Inhibition of angiogenesis by IL-32: possible role in asthma.

Authors:  Norbert Meyer; Janine Christoph; Heidi Makrinioti; Philippe Indermitte; Claudio Rhyner; Michael Soyka; Thomas Eiwegger; Maciej Chalubinski; Kerstin Wanke; Hiroyuki Fujita; Paulina Wawrzyniak; Simone Bürgler; Sherrie Zhang; Mübeccel Akdis; Günter Menz; Cezmi Akdis
Journal:  J Allergy Clin Immunol       Date:  2012-02-14       Impact factor: 10.793

Review 7.  IL-32: a newly-discovered proinflammatory cytokine.

Authors:  P Felaco; M L Castellani; M A De Lutiis; M Felaco; F Pandolfi; V Salini; D De Amicis; J Vecchiet; S Tete; C Ciampoli; F Conti; G Cerulli; A Caraffa; P Antinolfi; C Cuccurullo; A Perrella; T C Theoharides; P Conti; E Toniato; D Kempuraj; Y B Shaik
Journal:  J Biol Regul Homeost Agents       Date:  2009 Jul-Sep       Impact factor: 1.711

8.  IL-32γ inhibits cancer cell growth through inactivation of NF-κB and STAT3 signals.

Authors:  J H Oh; M-C Cho; J-H Kim; S Y Lee; H J Kim; E S Park; J O Ban; J-W Kang; D-H Lee; J-H Shim; S B Han; D C Moon; Y H Park; D-Y Yu; J-M Kim; S H Kim; D-Y Yoon; J T Hong
Journal:  Oncogene       Date:  2011-03-21       Impact factor: 9.867

9.  Expression levels of novel cytokine IL-32 in periodontitis and its role in the suppression of IL-8 production by human gingival fibroblasts stimulated with Porphyromonas gingivalis.

Authors:  Kazuhisa Ouhara; Toshihisa Kawai; Marcelo J B Silva; Tsuyoshi Fujita; Kouichi Hayashida; Nadeem Y Karimbux; Mikihito Kajiya; Hideki Shiba; Hiroyuki Kawaguchi; Hidemi Kurihara
Journal:  J Oral Microbiol       Date:  2012-03-16       Impact factor: 5.474

10.  Endogenous IL-32 controls cytokine and HIV-1 production.

Authors:  Marcel F Nold; Claudia A Nold-Petry; Gregory B Pott; Jarod A Zepp; Milene T Saavedra; Soo-Hyun Kim; Charles A Dinarello
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.426

View more
  5 in total

1.  Significant association between IL-32 gene polymorphisms and susceptibility to endometrial cancer in Chinese Han women.

Authors:  Xiuzhang Yu; Bin Zhou; Zhu Zhang; Qianqian Gao; Yanyun Wang; Yaping Song; Yan Pu; Yue Chen; Ruiqi Duan; Lin Zhang; Mingrong Xi
Journal:  Tumour Biol       Date:  2015-02-09

2.  Preliminary characterization of IL32 in basal-like/triple negative compared to other types of breast cell lines and tissues.

Authors:  Audrey Player; Tim Oguamanam; Jennifer Okanmelu; Kayla Burrell; Mario Hollomon
Journal:  BMC Res Notes       Date:  2014-08-07

3.  IL-32 exacerbates adenoid hypertrophy via activating NLRP3-mediated cell pyroptosis, which promotes inflammation.

Authors:  Junmei Zhang; Xuyuan Sun; Lingling Zhong; Bei Shen
Journal:  Mol Med Rep       Date:  2021-01-26       Impact factor: 2.952

Review 4.  IL-32: A Novel Pluripotent Inflammatory Interleukin, towards Gastric Inflammation, Gastric Cancer, and Chronic Rhino Sinusitis.

Authors:  Muhammad Babar Khawar; Muddasir Hassan Abbasi; Nadeem Sheikh
Journal:  Mediators Inflamm       Date:  2016-04-06       Impact factor: 4.711

Review 5.  Cytokine Patterns and Endotypes in Acute and Chronic Rhinosinusitis.

Authors:  Kathrin Scheckenbach; Martin Wagenmann
Journal:  Curr Allergy Asthma Rep       Date:  2016-01       Impact factor: 4.806

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.